No Time To Die, the twenty-fifth official chapter within the long-running 007 movie franchise and Daniel Craig’s swan track as license-to-kill agent James Bond, spent the higher a part of the COVID pandemic gathering mud on MGM’s cabinets ready for the suitable second to make its technique to theaters. This weekend, that lengthy wait lastly ended. So, did these 18 months of delays and date modifications repay? It relies upon whether or not you see the martini glass as half full or half empty. With its $56 million opening weekend in North America, the action-packed tentpole fell adequately in need of box-office soothsayers’ predictions; nevertheless, it nonetheless marks one of many most significant debuts of 2021.
Originally slated to hit theaters again in April 2020, the eagerly-awaited Bond sequel, pitting Craig’s bruised-knuckle MI6 agent towards Rami Malek’s supervillain, debuted to $56 million in 4,407 areas over the weekend, which translated to a $12,708 per-screen common.
Also not serving to issues: the movie’s prolonged 163-minute operating time, limiting what number of occasions the film may very well be proven every day.
As for the glass-half-full portion of 007’s efficiency, No Time to Die earned an A- grade from CinemaScore and a rosy 84% “fresh” ranking from critics on Rotten Tomatoes. Better but, the movie continued to scrub up abroad, the place it was unveiled per week sooner than it was within the States. After two weeks, the espionage epic has pulled in $257.3 million from overseas, bringing its present worldwide box-office whole to $313.3 million. Perhaps the most effective bit of reports for MGM (and Universal, who’s dealing with the movie’s overseas distribution duties) is that No Time to Die nonetheless hasn’t reached ticket patrons in China—one of many Bond franchise’s most profitable overseas markets. It opens there on October 29.